1. Home
  2. BIAF vs NBY Comparison

BIAF vs NBY Comparison

Compare BIAF & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.49

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

SELL

Current Price

$2.81

Market Cap

6.3M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
BIAF
NBY
Founded
2014
2000
Country
United States
United States
Employees
57
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
6.3M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
BIAF
NBY
Price
$1.49
$2.81
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.9K
478.4K
Earning Date
11-14-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$6,776,739.00
$10,302,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
$20.04
$32.05
P/E Ratio
N/A
$108.80
Revenue Growth
N/A
390.34
52 Week Low
$1.25
$0.46
52 Week High
$46.53
$4.44

Technical Indicators

Market Signals
Indicator
BIAF
NBY
Relative Strength Index (RSI) 39.85 86.06
Support Level $1.60 $1.00
Resistance Level $1.74 $1.11
Average True Range (ATR) 0.12 0.32
MACD 0.04 0.21
Stochastic Oscillator 33.34 82.68

Price Performance

Historical Comparison
BIAF
NBY

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: